Showing results (221-230 of 274) with videos related to
Sort By:
Pageof 28
Journal of Neural Transmission. Supplementum|April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseasesE Sofic, A Sapcanin, I Tahirovic, et al.Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[Alzheimer dementia. A clinical long-term study with quantitative neuropathology]P Fischer, H Lassmann, K Jellinger, et al.Journal of Neurochemistry|February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brainsP Riederer, E Sofic, W D Rausch, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1996
Creutzfeldt-Jakob disease in AustriaJ A Hainfellner, K Jellinger, H Diringer, et al.Brain Pathology (Zurich, Switzerland)|March 5, 2004
Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesionsR Höftberger, F Aboul-Enein, W Brueck, et al.Acta Neuropathologica|January 1, 1994
Amygdala pathology in Parkinson's diseaseH Braak, E Braak, D Yilmazer, et al.Neurobiology of Aging|July 1, 1996
On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitisC Bancher, H Leitner, K Jellinger, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 1999
Progression of falls in postmortem-confirmed parkinsonian disordersG K Wenning, G Ebersbach, M Verny, et al.Archives of Neurology|February 15, 2001
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disordersJ Müller, G K Wenning, M Verny, et al.Wiener Klinische Wochenschrift|March 5, 1976
[Neuropathology of renal transplantation (author's transl)]H Budka, K Jellinger, A Wolf, et al.Pageof 28